Rankia México Rankia Argentina Rankia Brasil Rankia Chile Rankia Colombia Rankia Czechia Rankia Deutschland Rankia España Rankia France Rankia Indonesia Rankia Italia Rankia Magyarország Rankia Netherlands Rankia Perú Rankia Polska Rankia Portugal Rankia Romania Rankia Türkiye Rankia United Kingdom Rankia USA
Acceder

Farmas USA

135K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
14,313 / 16,979
#114497

Re: Farmas USA

Creo que te voy a ayudar a que no bajen de 18. ¿Las opciones funcionan para alguien after hours o no?

EXEL

#114498

Re: Farmas USA

No. Horario regular. En las de ETFs duran un cuarto de hora más al cierre.

#114500

Re: Farmas USA

BMY

Emisión privada para la adquisición de CELG

private offering (the “Offering”) to sell senior unsecured notes (the
“Notes”).

The Offering is being conducted in connection with the previously
announced proposed acquisition (the “Merger”) of Celgene Corporation
(“Celgene”). Bristol-Myers Squibb expects to use the net proceeds from
the Offering to fund a portion of the aggregate cash portion of the
merger consideration to be paid to Celgene shareholders in connection
with the Merger and to pay related fees and expenses, with any remaining
proceeds being used for general corporate purposes.

The Notes have not been registered under the Securities Act of 1933, as
amended (the “Securities Act”), any state securities laws or the
securities laws of any other jurisdiction, and may not be offered or
sold in the United States, or for the benefit of U.S. persons, except
pursuant to an applicable exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act and
applicable state securities or blue sky laws. Accordingly, the Notes are
being offered in the United States only to persons reasonably believed
to be “qualified institutional buyers,” as that term is defined under
Rule 144A of the Securities Act, or outside the United States to persons
other than “U.S. persons” in accordance with Regulation S under the
Securities Act.

#114501

Re: Farmas USA

SPY

toma velon

XBI 

cierre de gap por proyección de esa bear flag … ya se vera … que en la zona de 82,5x se encuentra también el 50% del retroceso fibo ...

#114502

Re: Farmas USA

For all the political pressure to ease policy and the mixed signals on growth and inflation, the Fed refused to signal anything other than that it was still on pause, while Chair Jerome Powell said the factors dragging on inflation might be "transitory," not "persistent." That cooled over-excited U.S. shares on Wednesday, snapping the S&P 500's three-day winning streak and dragging down Wall Street. U.S. futures this morning are turning higher once again - with the DJIA up 59 points - as the focus shifts to the next round of corporate earnings as well as economic data on U.S. jobless claims and factory orders.

#114503

Re: Farmas USA

TEVA

reported quarterly earnings of $0.6 per share which beat the analyst consensus estimate of $0.58 by 3.45 percent. This is a 36.17 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $4.295 billion which missed the analyst consensus estimate of $4.38 billion by 1.94 percent. This is a 15.20 percent decrease over sales of $5.065 billion the same period last year.

Edito: fuera 15.85. No creo que aguante. Recojo profits y luego ya veré

#114504

Re: Farmas USA

BMY

Fuera 46.88